BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 34233378)

  • 1. A Randomized Controlled Pilot Study: Combined 595-nm Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride Topical Cream Superior to Oxymetazoline Hydrochloride Cream for Erythematotelangiectatic Rosacea.
    Sodha P; Suggs A; Munavalli GS; Friedman PM
    Lasers Surg Med; 2021 Dec; 53(10):1307-1315. PubMed ID: 34233378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosacea treatment with 532 nm KTP versus 595 nm pulsed dye laser-A prospective, controlled study.
    Nguyen L; Dierckxsens C; Kerscher M; Hartjen A; Schneider SW; Herberger K
    J Cosmet Dermatol; 2024 Apr; ():. PubMed ID: 38600654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 595 nm pulsed dye laser as an adjuvant intervention for post-comedone extraction erythema and comedone reduction: A randomized, split-face controlled trial.
    Bencharattanaphakhi R; Wananukul S; Tempark T; Chatproedprai S
    J Cosmet Dermatol; 2024 May; 23(5):1645-1653. PubMed ID: 38192163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of long-pulsed alexandrite laser therapy on facial redness and skin microbiota compositions in rosacea: A prospective, multicentre, single-arm clinical trial.
    Park S; Jang H; Seong SH; Kim JY; Lee EJ; Bae YJ; Ahn YJ; Kim J; Oh SH
    Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):. PubMed ID: 37890996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsed-dye laser as an effective treatment for recalcitrant granulomatous rosacea and a potential regulator of CXCL9 expression.
    Maeng JE; Son SW; Lee SJ; Kim JC; Kim S; Kang HY; Park YJ
    J Dermatol; 2024 May; 51(5):722-726. PubMed ID: 38009832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effectiveness of 595-nm Pulsed Dye Laser for the Treatment of Bilateral Cleft-Lip Scars in Asian Patients: A 6-Month Prospective, Randomized, Self-Controlled Trial.
    Chi H; Peng H; Zhao X; Zhou G; Shen L; Cai M
    Adv Wound Care (New Rochelle); 2024 Apr; ():. PubMed ID: 38258794
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study.
    Williamson T; Cheng WY; McCormick N; Vekeman F
    Am Health Drug Benefits; 2018 Apr; 11(2):97-106. PubMed ID: 29915642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Treatment of Corticosteroid-Induced Rosacea-Like Dermatitis with Platelet-Rich Plasma Mesotherapy: Report of Seven Cases.
    Fan X; Yin Y; Dou W; Li T; Xue P; Yang Q; Ma Q
    Dermatol Ther (Heidelb); 2021 Apr; 11(2):615-623. PubMed ID: 33539001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparison between modified kligman formulation versus kligman formulation and intense pulsed light in the treatment of the post-burn hyperpigmentation.
    Siadat AH; Iraji F; Bahrami R; Nilfroushzadeh MA; Asilian A; Shariat S; Nikyar Z; Bokaie S
    Adv Biomed Res; 2016; 5():125. PubMed ID: 27563635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, tolerance and acceptability of pulsed dye laser on facial and neckline telangiectasias in systemic scleroderma: a prospective open-label monocentric study in 21 patients.
    Kottler D; Dupechez L; Martin Silva N; Boutemy J; Dumont A; Maigné G; Aouba A; Dompmartin A
    J Cosmet Laser Ther; 2023 Nov; 25(5-8):77-85. PubMed ID: 38373440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of topical trametinib in rosacea: Results from a phase I clinical trial.
    Wladis EJ; Busingye J; Saavedra LK; Murdico A; Adam AP
    Skin Health Dis; 2024 Apr; 4(2):e346. PubMed ID: 38577058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurogenic rosacea successfully treated with neuromodulators and intense pulsed light.
    Hurtado DIC; Pérez APC; López RFR
    An Bras Dermatol; 2024; 99(2):296-297. PubMed ID: 38102048
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy Comparison of Pulsed Dye Laser vs. Microsecond 1064-nm Neodymium:Yttrium-Aluminum-Garnet Laser in the Treatment of Rosacea: A Meta-Analysis.
    Li Y; Wang R
    Front Med (Lausanne); 2021; 8():798294. PubMed ID: 35127754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Largest comparative analysis: Novel large spot size 595 nm, high-energy, pulsed dye laser reduces number of treatments for improvement of adult and pediatric port wine birthmarks.
    Sodha P; Wang JV; Aboul-Fettouh N; Martin K; Geronemus RG; Friedman PM
    Lasers Surg Med; 2023 Oct; 55(8):741-747. PubMed ID: 37293831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term inflammatory rosacea management with subantibiotic dose oral doxycycline 40 mg modified-release capsules once daily.
    Del Rosso JQ; Brantman S; Baldwin H
    Dermatol Ther; 2022 Jan; 35(1):e15180. PubMed ID: 34713539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids interaction with transient receptor potential family and implications in the treatment of rosacea.
    Garbutcheon-Singh KB; Smith SD
    Dermatol Ther; 2021 Nov; 34(6):e15162. PubMed ID: 34664381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Importance of Assessing Burning and Stinging when Managing Rosacea: A Review.
    Schaller M; Dirschka T; Lonne-Rahm SB; Micali G; Stein Gold LF; Tan J; Del Rosso J
    Acta Derm Venereol; 2021 Oct; 101(10):adv00584. PubMed ID: 34643244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on the British Association of Dermatologists guidelines for the management of people with rosacea 2021.
    Ho JSS; Asai Y
    Br J Dermatol; 2021 Oct; 185(4):689-690. PubMed ID: 34378187
    [No Abstract]   [Full Text] [Related]  

  • 19. A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.
    Zhang J; Jiang P; Sheng L; Liu Y; Liu Y; Li M; Tao M; Hu L; Wang X; Yang Y; Xu Y; Liu W
    Front Immunol; 2021; 12():609615. PubMed ID: 34322115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Bakuchiol in Dermatology: A Review of In Vitro and In Vivo Evidence.
    Greenzaid J; Friedman A; Sodha P
    J Drugs Dermatol; 2022 Jun; 21(6):624-629. PubMed ID: 35674758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.